The grand opening also highlights STADA Vietnam’s commitment to exporting high-quality products, Made in Vietnam, with the prestigious EU-GMP certificate to the global market, fostering growth in the nation’s pharmaceutical industry.
STADA Vetnam’s production facility is located in the province of Phu Yen. Several billion tablets are produced each year and there are plans for expansion. Although the site was originally built to just supply the Vietnamese market, the new STADA Vietnam plant has also been approved by European authorities to also supply the EU.
Andriy Samoylovych, general manager of STADA Pymepharco said, “This accomplishment can be attributed to the steadfast dedication and proficiency exhibited by our highly skilled Vietnamese workforce. Concurrently, the grand opening of our new office in Ho Chi Minh City marks a significant milestone, facilitating the expansion and fortification of our workforce.”
In the same vein, Walde stated, “The investment serves as further evidence that Vietnam represents a favourable destination for high-value production within a competitive industry. Additionally, it demonstrates how the EU-Vietnam Free Trade Agreement facilitates and encourages German investment in the country.”